Peptides for Hair Growth & Follicle Research

GHK-Cu works through multiple mechanisms relevant to hair growth: it stimulates dermal papilla cells (the growth centres of hair follicles), promotes blood vessel formation around follicles, extends the anagen growth phase, and inhibits TGF-beta — a key signal that triggers hair follicle regression.

Research on GHK-Cu for hair growth focuses primarily on androgenetic alopecia (pattern hair loss). Studies in cell cultures and animal models show it can enlarge miniaturised follicles and stimulate new growth. Its effects on other types of hair loss (alopecia areata, telogen effluvium) are less studied.

GHK-Cu and minoxidil work through different mechanisms. Minoxidil primarily acts as a vasodilator, while GHK-Cu directly stimulates follicle stem cells, promotes collagen around follicles, and provides antioxidant protection. Some researchers study both compounds together for potential synergistic effects.

Peptides Pharma's GHK-Cu vial contains a potent 60mg dose — one of the highest concentrations available for research. Published studies have used various concentrations, but higher doses have generally shown more pronounced effects on follicle proliferation and growth phase extension.